.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Medtronic
Fish and Richardson
Mallinckrodt
Julphar
Fuji
Citi
Daiichi Sankyo
Teva
Argus Health

Generated: December 13, 2017

DrugPatentWatch Database Preview

CELEXA Drug Profile

« Back to Dashboard

Which patents cover Celexa, and what generic alternatives are available?

Celexa is a drug marketed by Forest Labs and is included in two NDAs.

The generic ingredient in CELEXA is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Forest LabsCELEXAcitalopram hydrobromideSOLUTION;ORAL021046-001Dec 22, 1999DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Forest LabsCELEXAcitalopram hydrobromideTABLET;ORAL020822-003Jul 17, 1998ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Forest LabsCELEXAcitalopram hydrobromideTABLET;ORAL020822-001Apr 27, 2000ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Forest LabsCELEXAcitalopram hydrobromideTABLET;ORAL020822-002Jul 17, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Forest LabsCELEXAcitalopram hydrobromideTABLET;ORAL020822-004Jul 17, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Novartis
Moodys
Accenture
Merck
Baxter
Dow
Johnson and Johnson
Queensland Health
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot